Minn. Stat. § 241.33: Definitions

2026 edition · Last amended 2000 ·

In plain language

This section defines key terms used in the blood-borne pathogen testing laws for correctional facilities (sections 241.33 to 241.342). It covers what counts as a correctional facility, corrections employee, inmate, blood-borne pathogens like hepatitis B, hepatitis C, and HIV, and what counts as a 'significant exposure.'

Where this summary and the official text differ, the official text controls.

What this means for you

A ‘significant exposure’ requires both a specific type of contact (such as a needle stick or contact with broken skin) and contact with blood or potentially infectious body fluids. These definitions apply to both state and local correctional facilities and employees. Understanding these definitions is important for knowing when the blood-borne pathogen testing procedures apply.

Text of the law

Subdivision 1. Scope of definitions.

For purposes of sections 241.33 to 241.342, the following terms have the meanings given them.

Subd. 2. Blood-borne pathogens.

“Blood-borne pathogens” means pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

Subd. 3. Correctional facility.

“Correctional facility” means a state or local correctional facility.

Subd. 4. Corrections employee.

“Corrections employee” means an employee of a state or local correctional agency.

Subd. 5. Inmate.

“Inmate” means an individual who is in the custody or under the jurisdiction of the commissioner of corrections or a local correctional authority and is confined in a state or local correctional facility either before or after conviction.

Subd. 6. Significant exposure.

“Significant exposure” means contact likely to transmit a blood-borne pathogen, in a manner supported by the most current guidelines and recommendations of the United States Public Health Service at the time an evaluation takes place, that includes:

(1) percutaneous injury, contact of mucous membrane or nonintact skin, or prolonged contact of intact skin; and

(2) contact, in a manner that may transmit a blood-borne pathogen, with blood, tissue, or potentially infectious body fluids.

History: 2000 c 422 s 27

  2000 c 422 s 27